A bipartisan effort in the Senate Judiciary Committee has led to the passage of two bills designed to lower prescription drug ...

What should investors do when stocks are tanking over the short term? Three Motley Fool contributors think they've found great dividend stocks to own for the long term that pay you to wait for better ...

Washingtonians with schizophrenia are curious about a recently FDA-approved drug to treat their symptoms but much is unknown about how well it works.

Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...

New Jersey lawmakers have the opportunity to close a glaring drug-price loophole and give patients the transparency they’ve ...

Beyond the economic devastation, Trump’s tariffs have also landed the U.S. in legal hot water. China also announced Friday it ...

Rigel Pharmaceuticals is now reporting net income and has three marketed drugs, all of which can continue to grow. Read more ...

President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” ...

With a label expansion for Uplizna pushing the drug into an untouched rare disease market, Amgen is getting its money’s worth ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...